p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products - PubMed (original) (raw)
p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
Yili Yin et al. Nat Cell Biol. 2002 Jun.
Erratum in
- Nat Cell Biol 2002 Nov;4(11):912
Abstract
Activation of the p53 tumour suppressor protein can lead to cell-cycle arrest or apoptosis. p53 function is controlled by the mdm2 oncogene product, which targets p53 for proteasomal degradation. In this report we demonstrate that Mdm2 induces translation of the p53 mRNA from two alternative initiation sites, giving full-length p53 and another protein with a relative molecular mass (M(r)) of approximately 47K; we designate this protein as p53/47. This translation induction requires Mdm2 to interact directly with the nascent p53 polypeptide. The alternatively translated p53/47 does not contain the Mdm2-binding site and it lacks the most amino-terminal transcriptional-activation domain of p53. Increased expression of p53/47 stabilizes p53 in the presence of Mdm2, and alters the expression levels of p53-induced gene products. These results show how the interaction of Mdm2 with p53 leads to a change in the ratio of full-length p53 to p53/47 by inducing translation of both p53 proteins and the subsequent selective degradation of full-length p53. Thus, Mdm2 controls the expression levels of p53 through a dual mechanism that involves induction of synthesis and targeting for degradation.
Comment in
- Mini p53.
Ferrier V. Ferrier V. Nat Cell Biol. 2002 Jun;4(6):E156. doi: 10.1038/ncb0602-e156. Nat Cell Biol. 2002. PMID: 12042832 No abstract available.
Similar articles
- An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP. Midgley CA, et al. Oncogene. 2000 May 4;19(19):2312-23. doi: 10.1038/sj.onc.1203593. Oncogene. 2000. PMID: 10822382 - Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
Clark PA, Llanos S, Peters G. Clark PA, et al. Oncogene. 2002 Jul 4;21(29):4498-507. doi: 10.1038/sj.onc.1205558. Oncogene. 2002. PMID: 12085228 - A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein.
Veldhoen N, Metcalfe S, Milner J. Veldhoen N, et al. Oncogene. 1999 Nov 25;18(50):7026-33. doi: 10.1038/sj.onc.1203182. Oncogene. 1999. PMID: 10597303 - The MDM2-p53 interaction.
Moll UM, Petrenko O. Moll UM, et al. Mol Cancer Res. 2003 Dec;1(14):1001-8. Mol Cancer Res. 2003. PMID: 14707283 Review. - Mdm2: keeping p53 under control.
Piette J, Neel H, Maréchal V. Piette J, et al. Oncogene. 1997 Aug 28;15(9):1001-10. doi: 10.1038/sj.onc.1201432. Oncogene. 1997. PMID: 9285554 Review.
Cited by
- Two internal ribosome entry sites mediate the translation of p53 isoforms.
Ray PS, Grover R, Das S. Ray PS, et al. EMBO Rep. 2006 Apr;7(4):404-10. doi: 10.1038/sj.embor.7400623. Epub 2006 Jan 20. EMBO Rep. 2006. PMID: 16440000 Free PMC article. - Modulation of mammalian life span by the short isoform of p53.
Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, Sutherland A, Thorner M, Scrable H. Maier B, et al. Genes Dev. 2004 Feb 1;18(3):306-19. doi: 10.1101/gad.1162404. Genes Dev. 2004. PMID: 14871929 Free PMC article. - Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.
Stewart D, Ghosh A, Matlashewski G. Stewart D, et al. J Virol. 2005 Jul;79(14):8773-83. doi: 10.1128/JVI.79.14.8773-8783.2005. J Virol. 2005. PMID: 15994771 Free PMC article. - A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity.
Brubaker SW, Gauthier AE, Mills EW, Ingolia NT, Kagan JC. Brubaker SW, et al. Cell. 2014 Feb 13;156(4):800-11. doi: 10.1016/j.cell.2014.01.021. Cell. 2014. PMID: 24529381 Free PMC article. - Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
Mantawy EM, Esmat A, El-Bakly WM, Salah ElDin RA, El-Demerdash E. Mantawy EM, et al. Sci Rep. 2017 Jul 6;7(1):4795. doi: 10.1038/s41598-017-05005-9. Sci Rep. 2017. PMID: 28684738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous